MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer

Nicholas G. Nickols(VA Greater Los Angeles Healthcare System), Matthew B. Rettig(University of Southern California)
Prostate Cancer and Prostatic Diseases
February 25, 2019
Cited by 96


Related Papers